Surgical treatment for metastases of the cervical spine
- 298 Downloads
There are limited information and inconclusive results for the management of patients with cervical spine metastases. Therefore, we performed this study to evaluate the survival and outcome of these patients, and the surgical risk and complications.
Materials and Methods
We retrospectively studied 24 patients [14 men and 10 women; mean age, 71 years (range 54–89 years)], with cervical spine metastases, who underwent palliative surgical treatment, from December 2010 to December 2016. Mean follow-up was 14 months (range 1–42 months). We evaluated the survival and the outcome of the patients with respect to pain relief and neurological status, and the surgical risk and complications.
At the last follow-up, three patients were alive with disease, and 21 patients were dead with disease. Overall median survival was 14.8 months (range 1–47 months). A posterior approach was performed in 15 patients, an anterior approach with corpectomy and fusion in eight patients, and a two-stage combined approach in one patient. Overall, 21 patients experienced complete or almost complete, two patients mild, and one patient no pain relief; seven patients experienced complete neurological improvement, two patients moderate, while four patients remained stable. Overall, five patients experienced six complications including residual pain, sagittal malalignment with instability, and wound dehiscence; in five complications, a reoperation was necessary.
Palliative surgical treatment is usually performed in patients with metastatic bone disease of the cervical spine. Appropriate selection of the surgical technique is mandatory. However, the survival of the patients is dismal, and complications should be expected.
KeywordsCervical spine Spinal metastases Palliative treatment
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 8.Lee BH, Kim TH, Chong HS, Moon ES, Park JO, Kim HS, Kim SH, Lee HM, Cho YJ, Kim KN, Moon SH (2013) Prognostic factor analysis in patients with metastatic spine disease depending on surgery and conservative treatment: review of 577 cases. Ann Surg Oncol 20(1):40–46. doi: 10.1245/s10434-012-2644-4 CrossRefPubMedGoogle Scholar
- 9.Davarski AN, Kitov BD, Zhelyazkov CB, Raykov SD, Kehayov II, Koev IG, Kalnev BM (2013) Surgical management of metastatic tumors of the cervical spine. Folia Med (Plovdiv) 55(3–4):39–45Google Scholar
- 15.Brooks FM, Ghatahora A, Brooks MC, Warren H, Price L, Brahmabhatt P, De Vauvert S, John C, Farnworth E, Sulaiman E, Ahuja S (2014) Management of metastatic spinal cord compression: awareness of NICE guidance. Eur J Orthop Surg Traumatol 24(Suppl 1):S255–S259. doi: 10.1007/s00590-014-1438-8 CrossRefPubMedGoogle Scholar
- 16.Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648. doi: 10.1016/S0140-6736(05)66954-1 CrossRefPubMedGoogle Scholar
- 17.Ibrahim A, Crockard A, Antonietti P, Boriani S, Bunger C, Gasbarrini A, Grejs A, Harms J, Kawahara N, Mazel C, Melcher R, Tomita K (2008) Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2007. J Neurosurg Spine 8(3):271–278. doi: 10.3171/SPI/2008/8/3/271 CrossRefPubMedGoogle Scholar